DK2838539T3 - Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser - Google Patents
Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelserInfo
- Publication number
- DK2838539T3 DK2838539T3 DK13714917.5T DK13714917T DK2838539T3 DK 2838539 T3 DK2838539 T3 DK 2838539T3 DK 13714917 T DK13714917 T DK 13714917T DK 2838539 T3 DK2838539 T3 DK 2838539T3
- Authority
- DK
- Denmark
- Prior art keywords
- estrogender
- derivatives
- treatment
- neurological disorders
- neurological
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12164741.6A EP2653163A1 (en) | 2012-04-19 | 2012-04-19 | Estrogenic components for use in the treatment of neurological disorders |
| PCT/EP2013/057279 WO2013156329A1 (en) | 2012-04-19 | 2013-04-08 | Estrogenic components for use in the treatment of neurological disorders. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2838539T3 true DK2838539T3 (da) | 2017-11-27 |
Family
ID=48050711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13714917.5T DK2838539T3 (da) | 2012-04-19 | 2013-04-08 | Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9238035B2 (da) |
| EP (2) | EP2653163A1 (da) |
| JP (1) | JP6139662B2 (da) |
| CN (1) | CN104379148B (da) |
| AU (1) | AU2013248481B2 (da) |
| CA (1) | CA2869902C (da) |
| CY (1) | CY1119603T1 (da) |
| DK (1) | DK2838539T3 (da) |
| ES (1) | ES2647111T3 (da) |
| HR (1) | HRP20171627T1 (da) |
| HU (1) | HUE034902T2 (da) |
| LT (1) | LT2838539T (da) |
| NO (1) | NO2838539T3 (da) |
| PL (1) | PL2838539T3 (da) |
| PT (1) | PT2838539T (da) |
| RS (1) | RS56595B1 (da) |
| RU (1) | RU2627846C2 (da) |
| SI (1) | SI2838539T1 (da) |
| SM (1) | SMT201700531T1 (da) |
| WO (1) | WO2013156329A1 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2714710T (pt) | 2011-06-01 | 2016-07-12 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
| AU2012264601C1 (en) | 2011-06-01 | 2018-01-25 | Estetra Srl | Process for the production of estetrol intermediates |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| WO2016187558A2 (en) * | 2015-05-20 | 2016-11-24 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Method to improve neurologic outcomes in temperature managed patients |
| MD3310346T2 (ro) | 2015-06-18 | 2021-06-30 | Estetra Sprl | Comprimată orodispersabilă ce conține estetrol |
| JP6866560B2 (ja) * | 2015-06-18 | 2021-04-28 | エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ | エステトロール成分を含有する口腔内崩壊性投与単位 |
| HUE054589T2 (hu) * | 2015-06-18 | 2021-09-28 | Estetra Sprl | Szájban diszpergálódó esztetrol tartalmú tabletta |
| MY195019A (en) * | 2015-06-18 | 2023-01-03 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| KR102712911B1 (ko) | 2016-08-05 | 2024-10-04 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
| CN107260712A (zh) * | 2017-06-22 | 2017-10-20 | 中国人民解放军第三军医大学 | 奥培米芬在制备促进髓鞘形成和再生的药物中的应用 |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| HU231240B1 (hu) | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
| CN113243332B (zh) * | 2020-02-07 | 2023-07-28 | 上海市东方医院（同济大学附属东方医院） | 一种广泛脑区神经元树突发育障碍动物模型的制备与应用 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| HUP2400151A1 (hu) | 2024-02-28 | 2025-09-28 | Richter Gedeon Nyrt | Ösztetrol-monohidrát kristályosítási eljárás |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2378898A (en) * | 2001-08-14 | 2003-02-26 | Hunter Fleming Ltd | Prophylactic and therapeutic use of hydroxysteroids |
| WO2003103683A1 (en) | 2002-06-11 | 2003-12-18 | Pantarhei Bioscience B.V. | Use of estetrol and analogues for treating or preventing cardiovascular pathologies, in particular atherosclerosis |
| CN1691947B (zh) * | 2002-06-11 | 2011-11-23 | 潘塔希生物科学股份有限公司 | 雌激素成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述雌激素成分的药物组合物 |
| EP3045177A1 (en) * | 2005-09-26 | 2016-07-20 | The Regents of The University of California | Estriol therapy for autoimmune and neurodegenerative diseases and disorders |
| CA2636638C (en) * | 2006-01-09 | 2014-02-18 | Pantarhei Bioscience B.V. | A method of treating an acute vascular disorder |
| CN102014924B (zh) * | 2007-06-21 | 2012-07-18 | 潘塔希生物科学股份有限公司 | 用雌激素治疗胎粪吸入综合征 |
| CA2704921C (en) * | 2007-11-06 | 2015-11-24 | Ellis L. Kline | Compositions and methods for treating parkinson's disease and related disorders |
| CN101884638B (zh) * | 2010-07-09 | 2011-11-09 | 中山大学 | 5α-雄甾(烷)-3β,5,6β-三醇在制备神经元保护药物中的应用 |
-
2012
- 2012-04-19 EP EP12164741.6A patent/EP2653163A1/en not_active Withdrawn
-
2013
- 2013-04-08 PT PT137149175T patent/PT2838539T/pt unknown
- 2013-04-08 CA CA2869902A patent/CA2869902C/en active Active
- 2013-04-08 ES ES13714917.5T patent/ES2647111T3/es active Active
- 2013-04-08 RU RU2014145800A patent/RU2627846C2/ru active
- 2013-04-08 EP EP13714917.5A patent/EP2838539B1/en active Active
- 2013-04-08 PL PL13714917T patent/PL2838539T3/pl unknown
- 2013-04-08 DK DK13714917.5T patent/DK2838539T3/da active
- 2013-04-08 JP JP2015506173A patent/JP6139662B2/ja active Active
- 2013-04-08 SM SM20170531T patent/SMT201700531T1/it unknown
- 2013-04-08 RS RS20171122A patent/RS56595B1/sr unknown
- 2013-04-08 HU HUE13714917A patent/HUE034902T2/hu unknown
- 2013-04-08 AU AU2013248481A patent/AU2013248481B2/en active Active
- 2013-04-08 US US14/395,465 patent/US9238035B2/en active Active
- 2013-04-08 SI SI201330825T patent/SI2838539T1/sl unknown
- 2013-04-08 WO PCT/EP2013/057279 patent/WO2013156329A1/en not_active Ceased
- 2013-04-08 CN CN201380020555.6A patent/CN104379148B/zh active Active
- 2013-04-08 LT LTEP13714917.5T patent/LT2838539T/lt unknown
- 2013-04-08 HR HRP20171627TT patent/HRP20171627T1/hr unknown
- 2013-04-08 NO NO13714917A patent/NO2838539T3/no unknown
-
2017
- 2017-11-14 CY CY20171101193T patent/CY1119603T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2838539T (pt) | 2017-11-15 |
| ES2647111T3 (es) | 2017-12-19 |
| SI2838539T1 (sl) | 2017-12-29 |
| HUE034902T2 (hu) | 2018-03-28 |
| CN104379148A (zh) | 2015-02-25 |
| HRP20171627T1 (hr) | 2017-12-01 |
| RU2014145800A (ru) | 2016-06-10 |
| EP2838539A1 (en) | 2015-02-25 |
| RU2627846C2 (ru) | 2017-08-14 |
| CN104379148B (zh) | 2017-08-25 |
| AU2013248481B2 (en) | 2017-02-16 |
| RS56595B1 (sr) | 2018-02-28 |
| CA2869902C (en) | 2019-07-02 |
| AU2013248481A1 (en) | 2014-10-30 |
| EP2653163A1 (en) | 2013-10-23 |
| LT2838539T (lt) | 2017-11-27 |
| EP2838539B1 (en) | 2017-08-16 |
| NO2838539T3 (da) | 2018-01-13 |
| JP2015514731A (ja) | 2015-05-21 |
| WO2013156329A1 (en) | 2013-10-24 |
| CY1119603T1 (el) | 2018-04-04 |
| PL2838539T3 (pl) | 2018-01-31 |
| US20150133419A1 (en) | 2015-05-14 |
| US9238035B2 (en) | 2016-01-19 |
| SMT201700531T1 (it) | 2018-01-11 |
| JP6139662B2 (ja) | 2017-05-31 |
| CA2869902A1 (en) | 2013-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2838539T3 (da) | Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser | |
| LT2961410T (lt) | Pirazolopirimidino darinių naudojimas gydant su pi3k susijusius sutrikimus | |
| DK2800581T3 (da) | Fremgangsmåder til behandling af adfærdssymptomer på neurologiske og mentale forstyrrelser | |
| DK2938740T3 (da) | Kimære fgf19-peptider til anvendelse til behandling af galdesyrelidelser | |
| DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
| PT2919796T (pt) | Utilização de akkermansia para o tratamento de distúrbios metabólicos | |
| IL239355A0 (en) | Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders | |
| SI2707029T1 (sl) | Metode zdravljenja ali preprečevanja s holesterolom povezanih motenj | |
| HRP20181227T1 (hr) | Metode za liječenje atopijskog dermatitisa primjenom antagonista il-4r | |
| CO6751293A2 (es) | Derivados heterocíclicos novedosos y su uso en e tratamiento de trastornos neurológicos | |
| HUE059041T2 (hu) | Eljárás KIT-tel összefüggõ rendellenességek kezelésére alkalmas kompozíciók elõállítására | |
| DK2836200T3 (da) | Termoreversible hydrogelpræparater til anvendelse i behandlingen af lidelser i urothelium | |
| DK2981269T3 (da) | Behandling af stofskifteforstyrrelser hos hestedyr | |
| PL2830654T3 (pl) | Sposoby i kompozycje do leczenia zapalenia | |
| DK3040336T3 (da) | Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande | |
| PL2768859T3 (pl) | Antagoniści IL17C do leczenia zaburzeń zapalnych | |
| PL3466425T3 (pl) | Zastosowanie pochodnych glutarimidu w leczeniu chorób eozynofilowych | |
| HUE037179T2 (hu) | Gyógyászati kompozíciók izom-rendellenességek kezelésére | |
| EP2869833A4 (en) | TREATMENT OF INFLAMMATORY SKIN DISORDERS | |
| HUE046508T2 (hu) | Orvepitant krónikus viszketés kezelésére | |
| DK2807170T3 (da) | Phragmalin-limonoider til behandlingen af seksuel dysfunktion | |
| DK2819667T3 (da) | Retinalderivater til anvendelse til forbedring af synsfunktionen | |
| DK2830645T3 (da) | Neuregulin til anvendelse i behandling af perifær nervelæsion | |
| PL2846791T3 (pl) | HPN-100 do zastosowania do leczenia zaburzeń retencji azotu | |
| SMT201600395B (it) | Derivati di pantotenato per il trattamento di disturbi neurologici |